Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease
Nephron · 2024
DOI: 10.1159/000530918 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephron, 2024. Verfasst von Ibrahim Sandokji und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Taibah University College of Medicine, Medina, Saudi Arabia, isandokji@gmail.com. Hauptthemen laut MEDLINE: Proteomics, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NCCIH NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background: Due to the complexity of chronic kidney disease (CKD) pathophysiology, biomarkers representing different mechanistic pathways have been targeted for the study and development of novel biomarkers. The discovery of clinically useful CKD biomarkers would allow for the identification of those children at the highest risk of kidney function decline for timely interventions and enrollment in clinical trials. Summary: Glomerular filtration rate and proteinuria are traditional biomarkers to classify and prognosticate CKD progression in clinical practice but have several limitations. Over the recent decades, novel biomarkers have been identified from blood or urine with metabolomic screening studies, proteomic screening studies, and an improved knowledge of CKD pathophysiology. This review highlights promising biomarkers associated with the progression of CKD that could potentially serve as future prognostic markers in children with CKD. Key Messages: Further studies are needed in children with CKD to validate putative biomarkers, particularly candidate proteins and metabolites, for improving clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Taibah University College of Medicine, Medina, Saudi Arabia, isandokji@gmail.com.
- Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
- Division of Nephrology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Department of Pediatrics, Section of Nephrology, Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, Connecticut, USA.
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- NCCIH NIH HHS
Zitieren
APA
Sandokji, I., Xu, Y., Denburg, M., Furth, S., Abraham, A. G., & Greenberg, J. H. (2024). Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease. Nephron. https://doi.org/10.1159/000530918
Vancouver
Sandokji I, Xu Y, Denburg M, Furth S, Abraham AG, Greenberg JH. Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease. Nephron. 2024. doi:10.1159/000530918
BibTeX
@article{Sandokji2024,
author = {Sandokji, Ibrahim and Xu, Yunwen and Denburg, Michelle and Furth, Susan and Abraham, Alison G and Greenberg, Jason H},
title = {Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease},
journal = {Nephron},
year = {2024},
doi = {10.1159/000530918}
}
EUVIMED